UK's PureTech climbs after successful US FDA meeting
** Shares of PureTech Health PRTC.L up 4.1% at 127p ** Stock among top gainers on FTSE Small Cap index .FTSC, which is flat ** Co announces successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis ** YTD, including session’s gains, stock down about 15%, while .FTSC is up nearly 8% (Reporting by Judes Joseph in Bengaluru) ((judes.joseph@thomsonreuters.com;))